A Study Comparing Modified Lund Concept and Cerebral Perfusion Pressure-targeted Therapy in Secondary Brain Ischaemia.
Launched by UNIVERSITY OF SARAJEVO · Sep 20, 2010
Trial Information
Current as of August 29, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patients with subarachnoid haemorrhage who had anterior circulation aneurysm rupture only
- • multiple anterior aneurysm rupture
- • severe traumatic brain injury with isolated head injury and intradural focal lesions only
- Exclusion Criteria:
- • Glasgow Outcome Score of 3 with or without brainstem reflexes
- • Significant co-morbidities
- • posterior circulation aneurysm
- • multisystem injuries
- • diffuse axonal injuries
About University Of Sarajevo
The University of Sarajevo, a distinguished academic institution in Bosnia and Herzegovina, is committed to advancing medical research and improving healthcare outcomes through rigorous clinical trials. With a focus on innovation and collaboration, the university leverages its extensive resources and expertise in various fields of medicine to conduct studies that address pressing health challenges. By fostering partnerships with healthcare professionals and research organizations, the University of Sarajevo aims to contribute valuable insights to the global medical community and enhance the quality of life for patients through evidence-based findings.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sarajevo, , Bosnia And Herzegovina
Patients applied
Trial Officials
Kemal Dizdarevic, MD, MSc, PhD
Principal Investigator
Department of Neurosurgery, Clinical Centre University of Sarajevo, Sarajevo, Bosnia and Herzegovina
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials